294 related articles for article (PubMed ID: 8455942)
1. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
Brown PH; Alani R; Preis LH; Szabo E; Birrer MJ
Oncogene; 1993 Apr; 8(4):877-86. PubMed ID: 8455942
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of a dominant-negative mutant of c-Jun.
Brown PH; Chen TK; Birrer MJ
Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
[TBL] [Abstract][Full Text] [Related]
3. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
Kim S; Brown PH; Birrer MJ
Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
[TBL] [Abstract][Full Text] [Related]
5. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.
Wu WS; Lin JK; Wu FY
Oncogene; 1992 Nov; 7(11):2287-94. PubMed ID: 1437150
[TBL] [Abstract][Full Text] [Related]
7. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
8. Transformation suppressor activity of a Jun transcription factor lacking its activation domain.
Lloyd A; Yancheva N; Wasylyk B
Nature; 1991 Aug; 352(6336):635-8. PubMed ID: 1907719
[TBL] [Abstract][Full Text] [Related]
9. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
10. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
[TBL] [Abstract][Full Text] [Related]
11. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
12. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).
Schuringa JJ; Timmer H; Luttickhuizen D; Vellenga E; Kruijer W
Cytokine; 2001 Apr; 14(2):78-87. PubMed ID: 11356008
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
14. Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potencies.
Brown PH; Kim SH; Wise SC; Sabichi AL; Birrer MJ
Cell Growth Differ; 1996 Aug; 7(8):1013-21. PubMed ID: 8853897
[TBL] [Abstract][Full Text] [Related]
15. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
Hirai S; Yaniv M
New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
[TBL] [Abstract][Full Text] [Related]
16. Heterodimerization with c-Fos is not required for cell transformation of chicken embryo fibroblasts by Jun.
Hughes M; Sehgal A; Hadman M; Bos T
Cell Growth Differ; 1992 Dec; 3(12):889-97. PubMed ID: 1472469
[TBL] [Abstract][Full Text] [Related]
17. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
Jalava A; Mai S
Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020
[TBL] [Abstract][Full Text] [Related]
18. fos-jun Conspiracy: implications for the cell.
Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
Smeal T; Binetruy B; Mercola DA; Birrer M; Karin M
Nature; 1991 Dec; 354(6353):494-6. PubMed ID: 1749429
[TBL] [Abstract][Full Text] [Related]
20. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
